DNA typing of HLA in the patients with moyamoya disease

Japanese Journal of Human Genetics

Volumn 42, Issue 4, 1997, Pages 499-505

  Inoue, Takuya K ^a   Ikezaki, Kiyonobu ^b   Sasazuki, Takehiko ^a   Uno, Takashi ^b   Kamikawaji, Nobuhiro ^a   Matsushima, Toshio ^b   Fukul, Masashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Genetic; HLA typing; Moyamoya disease

Indexed keywords

DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; OLIGONUCLEOTIDE PROBE; ONSET AGE; POLYMERASE CHAIN REACTION;

EID: 33747149870     PISSN: 09168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02767027     Document Type: Article

References (39)

1. Achord JL, Gunn CH, Jackson JF (1982): Regional enteritis and HLA concordance in multiple sibrings. Dig Dis Sei 27: 330-332
2. 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol 154: 281-288
3. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K (1995): Human leukocyte antigen in patients with moyamoya disease. Stroke 26: 415-417
4. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayer WP, Darham P, Sasazuki T, Schneider GMT, Strominger JL, Svejguard A, Terasaki PI (1995): Nomenclature for factors of the HLA system. Tissue Antigens 46: 1-18
5. Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M (1994): Protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 56: 465-467
6. Date Y, Kimura A, Kato H, Sasazuki T (1996): DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 47: 93-101
7. Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T (1992): HLA-linked susceptibility and resistance to Takayasu Arteritis. Heart Vessels Suppl 7: 73-80
8. Dong RP, Kimura A, Hashimoto H, Akizuki M, Nishimura Y, Sasazuki T (1993): Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 41: 20-25
9. Fukui M, Kawano T (1996): Follow-up study of registered cases in 1995. In: Annual Report 1995 of the Research Committee on Spontaneous Occlusion of the Circle of Willis, pp 12 16 (in Japanese)
10. Gadoth N (1993): On the probrem of essential and secondary moyamoya and vascular dysplasia in Down syndrome. Brain Dev 15: 317-318
11. Goto Y, Yonekawa Y (1992): Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32: 883-886
12. Haldane S (1956): The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20: 309-311
13. Hirayama K, Matsushita S, Kikuchi I, luchi M, Ohta N, Sasazuki T (1987): HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327: 426-430
14. Hosoda Y (1984): Pathology of so-called spontaneous occlusion of the circle of willis. Pathol Annu 19: 221-244
15. Hugot JP, Laurent-Puig P, Gower-Rousseau, Caillat-Zucman S, Beaugerie L, Dupas JL, Gossum AV, Bonaïti-Pellie C, Cortot A, Thomas G, the G.E.T.A.I.D. (1994): Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. Am J Med Genet 52: 207-213
16. Ikeda E, Hosoda Y (1993): Distribution of the thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of willis: cerebrovascular moyamoya disease. Clin Neuropathol 12: 44-48
17. Ikeda E, Maruyama I, Hosoda Y (1993): Expression of thrombomodulin in patients with spontaneous occlusion of the circle of willis. Stroke 24: 657-660
18. Ikezaki K, Han HD, Kawano T (I997): Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99 Suppl.2: S6-S10
19. Kanai N, Fukuyama Y (1992): A genetic study of spontaneous occlusion of the circle of willis (Moyamoya disease). Tokyo Joshi Ikadaigaku Zasshi 62: 1227-1258 (in Japanese with English abstract)
20. Kimura A, Sasazuki T (1992): Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991: Proceeding of the Eleventh International Workshop and Conference. Vol 1. Oxford University Press, Oxford, pp 397-419
21. Kimura A, Dong RP, Harada H, Sasazuki T (1992): DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 40: 5-12
22. Kitahara T, Okumura K, Senba A, Yamaura A, Makino H (1982): Genetic and immunologie analysis on moyamoya. J Neurol Neurosurg Psychiatry 45: 1048-1052
23. Kitamura K (1988): Revision of the diagnostic guide of the "Spontaneous occlusion of the circle of Willis." In: Annual Report 1987 of the Research Committee on Spontaneous Occlusion of the Circle of Willis. pp 119-122 (in Japanese)
24. Kudo T (1968): Spontaneous occlusion of the circle of Willis: a disease apparently confined to Japanese. Neurology 20: 485-496
25. Masuda J, Ogata J, Yutani C (1993): Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24: 1960-1967
26. Miettinen O (1976): Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226-235
27. Nishimoto A, Takeuchi S (1968): Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg 29: 255-260
28. Nishimura Y, Sasazuki T (1987): Suppressor T cells control the HLA-linked low responsiveness to streptococcal antigen in human. Nature 327: 426-430
29. Panegyres PK, Morris JG, O'Neill PJ, Balleine R (1993): Moyamoya-like disease with inflammation. Eur Neurol 33: 260-263
30. Pavlakis SG, Verlander PC, Gould RJ, Strimling BC (1995): Fanconi anemia and moyamoya: evidence for an association. Neurology 45: 998-1000
31. Sasazuki T, Nishimura Y, Muto M, Onta N (1983): HLA-linked genes controlling the immune response and disease susceptibility. Immunol Rev 70: 51-75
32. Suzuki J, Takaku A (1969): Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299
33. Suzuki J, Kodama N (1983): Moyamoya disease: a review. Stroke 14: 104-109
34. Suzuki H, Hoshimaru M, Takahashi JA, Kikuchi H, Fukumoto M, Ohta M, Itoh N, Hatanaka M (1994): Immunohistochemical reaction for growth factor receptor in arteries of patients with moyamoya disease. Neurosurgery 35: 20-25
35. Todd JA, Acha-Orbea H, Bell JI, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jakob CO, Mcdermott M, Sinha A A, Timmerman L, Steinmann L, Mcdevitt HO (1988): A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003-1009
36. Wakai K, Tamakoshi A, Ohno Y, Kawamura T, Ikezaki K, Fukui M (1996): Epidemiology of moyamoya disease in Japan: Findings from a nationwide survey. In: Annual Report 1995 of the Research Committee on Spontaneous Occlusion of the Circle of Willis, pp 33-38 (in Japanese)
37. Woody RC, Perrot LJ, Beck SA (1992): Neurofibromatosis cerebral vasculopathy in an infant: clinical, neuroradiologic, and neuropathologic studies. Pediatr Pathol 12: 613-619
38. Woolf B (1955): On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253
39. Yamashita M, Oka K, Tanaka K (1991): Histopathology of the brain vascular network in moyamoya disease. Stroke 22: 1358-1362